Sutro Biopharma Revenue 2017-2022 | STRO
Sutro Biopharma revenue from 2017 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Sutro Biopharma Annual Revenue
(Millions of US $) |
| 2021 |
$62 |
| 2020 |
$43 |
| 2019 |
$43 |
| 2018 |
$38 |
| 2017 |
$52 |
| 2016 |
$60 |
Sutro Biopharma Quarterly Revenue
(Millions of US $) |
| 2022-03-31 |
$6 |
| 2021-12-31 |
$11 |
| 2021-09-30 |
$9 |
| 2021-06-30 |
$28 |
| 2021-03-31 |
$15 |
| 2020-12-31 |
$8 |
| 2020-09-30 |
$18 |
| 2020-06-30 |
$9 |
| 2020-03-31 |
$7 |
| 2019-12-31 |
$11 |
| 2019-09-30 |
$12 |
| 2019-06-30 |
$11 |
| 2019-03-31 |
$9 |
| 2018-12-31 |
$19 |
| 2018-09-30 |
$8 |
| 2018-06-30 |
$6 |
| 2018-03-31 |
$6 |
| 2017-12-31 |
|
| 2017-09-30 |
$17 |
| 2016-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.208B |
$0.062B |
|
Sutro Biopharma Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Its product pipeline consists of STRO-001 and STRO-002 which are in clinical stage. Sutro Biopharma Inc. is based in South San Francisco, California.
|
